Indegene Logo png.png
Indegene and SynPhNe join hands to bring relief to stroke and TBI victims worldwide
16 mai 2023 07h00 HE | Indegene Inc
PRINCETON, N.J. and SINGAPORE, May 16, 2023 (GLOBE NEWSWIRE) -- Indegene, a digital-first, life sciences commercialization company, announced today that it is joining hands with SynPhNe, to bring...
22157.jpg
Asia-Pacific Pharmaceutical Industry Outlook Report 2023-2027: Top Predictions, Key Trends, Macroeconomic Factors, Revenues, Country-specific Trends, Opportunities
20 avr. 2023 09h18 HE | Research and Markets
Dublin, April 20, 2023 (GLOBE NEWSWIRE) -- The "Asia-Pacific Pharmaceutical Industry Outlook 2023" report has been added to ResearchAndMarkets.com's offering. Asia-Pacific's pharmaceutical market...
Specialty Pharmacy Patient Choice Award Finalists
MMIT Announces Finalists of the Eighth-Annual Specialty Pharmacy Patient Choice Awards
11 avr. 2023 08h00 HE | Managed Markets Insight & Technology, LLC
Yardley, PA, April 11, 2023 (GLOBE NEWSWIRE) -- Managed Markets Insight & Technology (MMIT), the trusted go-to-market partner for overcoming barriers to patient access, has announced the...
MMIT Announces Winne
MMIT Announces Winners of Q4 2022 Patient Access Awards
30 mars 2023 08h00 HE | Managed Markets Insight & Technology, LLC
Yardley, PA, March 30, 2023 (GLOBE NEWSWIRE) -- Managed Markets Insight & Technology (MMIT), the leading provider of market access data, analytics and insights, has announced the winners of its...
22157.jpg
The Pharma Mini MBA Training Course (November 8-10, 2023)
20 mars 2023 07h33 HE | Research and Markets
Dublin, March 20, 2023 (GLOBE NEWSWIRE) -- The "The Pharma Mini MBA Training Course" conference has been added to ResearchAndMarkets.com's offering. Working in the highly competitive...
22157.jpg
Pharma Pricing and Reimbursement and Market Access Risk Scores (MARS) Overview of 2022 and Outlook for 2023
09 mars 2023 10h53 HE | Research and Markets
Dublin, March 09, 2023 (GLOBE NEWSWIRE) -- The "Pharma Pricing and Reimbursement and Market Access Risk Scores (MARS) by Region - Overview of 2022 and Outlook for 2023" report has been added to ...
22157.jpg
Register for this 3 Day Pharma Mini MBA Training Course: May 3-5, 2023
20 févr. 2023 04h23 HE | Research and Markets
Dublin, Feb. 20, 2023 (GLOBE NEWSWIRE) -- The "The Pharma Mini MBA Training Course" conference has been added to ResearchAndMarkets.com's offering. Working in the highly competitive...
22157.jpg
Register for This 3 Day Pharma Mini MBA Training Course: August 2 - 4, 2023 - Hear About the Latest Strategic Technology Innovations Being Used and Developed
17 févr. 2023 04h13 HE | Research and Markets
Dublin, Feb. 17, 2023 (GLOBE NEWSWIRE) -- The "The Pharma Mini MBA Training Course" conference has been added to ResearchAndMarkets.com's offering. Working in the highly competitive...
VPM_logo for GBN.jpg
VPM oversees clinical trial and translational project management – Positive Phase I data of client Memo Therapeutics AG
25 janv. 2023 04h00 HE | VPM - Vakzine Project Management GmbH
HANNOVER, Germany, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Vakzine Projekt Management GmbH (VPM), a German drug development consultancy and service provider supporting small and medium pharma and biotech...
MMIT Patient Access Awards
MMIT Announces the Winners of the Q3 2022 Patient Access Awards
06 janv. 2023 07h00 HE | Managed Markets Insight & Technology, LLC
Yardley, PA, Jan. 06, 2023 (GLOBE NEWSWIRE) -- Managed Markets Insight & Technology (MMIT)—the trusted go-to-market partner for overcoming barriers to patient access—has announced the winners of...